SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B

Published:2017-02-04 Issue:10 Volume:8 Page:17127-17139
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hoan Nghiem Xuan¹²³,Van Tong Hoang¹³⁴,Giang Dao Phuong¹²³,Cuong Bui Khac³⁴,Toan Nguyen Linh³⁴,Wedemeyer Heiner⁵,Bock C. Thomas⁶,Kremsner Peter G.¹³,Song Le Huu²³,Velavan Thirumalaisamy P.¹³⁴⁷

Affiliation:

1. Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany

2. Institute of Clinical Infectious Diseases, 108 Military Central Hospital, Hanoi, Vietnam

3. Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam

4. Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam

5. German Center for Infection Research, Department for Gastroenterology, Hepatology, and Endocrinology, Medical School Hannover, Germany

6. Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany

7. Faculty of Medicine, Duy Tan University, Da Nang, Vietnam

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of association between SOCS3 and SOCS7 polymorphisms and psoriasis;Immunity, Inflammation and Disease;2022-09-15

2. Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma;Cancers;2022-07-22

3. Suppressor of cytokine signaling proteins 1 and 3 and hepatitis B virus infection;World Chinese Journal of Digestology;2020-11-08

4. Genetic variability of molecules involved in the disease pathogenesis in Leishmania infection;Experimental Parasitology;2020-11

5. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors;Frontiers in Oncology;2020-08-07